| Followers | 22 |
| Posts | 2895 |
| Boards Moderated | 0 |
| Alias Born | 08/14/2016 |
Monday, December 13, 2021 11:58:29 AM
Thanks for sharing. Positive post. Just like the PR said
Production of our MS drug for the upcoming Phase II clinical study. We’re also working closely with the Defense Threat Reduction Agency (www.DTRA.mil) on our nerve agent counter-measure program and are seeking funding there.
Guess what we are...... that's right.....GOLDEN
Production of our MS drug for the upcoming Phase II clinical study. We’re also working closely with the Defense Threat Reduction Agency (www.DTRA.mil) on our nerve agent counter-measure program and are seeking funding there.
Guess what we are...... that's right.....GOLDEN
Recent NPHC News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/06/2026 09:10:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/25/2026 06:38:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/11/2026 07:22:37 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/17/2026 07:11:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/02/2026 06:52:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/23/2025 06:15:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/17/2025 10:08:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/24/2025 06:48:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/28/2025 08:02:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/23/2025 05:43:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/16/2025 08:38:46 PM
